Takara Bio Inc. provided earnings guidance for the fiscal year ending March 31, 2021. For the year, the company expected net sale was JPY 45,200 million, operating profit was JPY 12,000 million and net income attributable to owners of the parent was JPY 7,800 million or JPY 64.78 per share.